Use of advanced heart failure therapies in Duchenne muscular dystrophy

BACKGROUND: As survival and neuromuscular function in Duchenne Muscular Dystrophy (DMD) improve with glucocorticoid therapy and respiratory advances, the proportion of cardiac deaths is increasing. Little is known about the use and outcomes of advanced heart failure (HF) therapies in this population...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Prog Pediatr Cardiol
Main Authors: Wittlieb-Weber, Carol A., Villa, Chet R., Conway, Jennifer, Bock, Matthew J., Gambetta, Katheryn E., Johnson, Jonathan N., Lal, Ashwin K., Schumacher, Kurt R., Law, Sabrina P., Deshpande, Shriprasad R., West, Shawn C., Friedland-Little, Joshua M., Lytrivi, Irene D., McCulloch, Michael A., Butts, Ryan J., Weber, David R., Knecht, Kenneth R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6663084/
https://ncbi.nlm.nih.gov/pubmed/31360053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ppedcard.2019.01.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados